TY  - GEN 
AU  - Martinez Lago, Nieves Purificacion
AU  - García, S.C.
AU  - Alonso de Castro, Beatriz
AU  - Gómez-Randulfe Rodríguez, M.I.
AU  - Campos, M.C.
AU  - Villarroel, P.G.
AU  - Fernández, M.S.
AU  - De La Cámara Gómez, Juan Cruz
AU  - Reinoso, C.R.
AU  - Castiñeiras, A.C.
AU  - Méndez, J.C.M.
AU  - Insua, Y.V.
AU  - Fernández Montes, Ana
PY  - 2022
SN  - 1932-6203
UR  - http://hdl.handle.net/20.500.11940/20877
AB  - Background The VELOUR study showed the benefit of FOLFIRI-Aflibercept (FA) versus FOLFIRI in patients with metastatic colorectal cancer (mCRC) in second-line treatment. However, only 36% of the included patients were ?65 years. Thus, we seek to...
LA  - eng
TI  - Efficacy and safety of FOLFIRI/aflibercept (FA) in an elderly population with metastatic colorectal cancer (mCRC) after failure of an oxaliplatin-based regimen
DO  - 10.1371/journal.pone.0269399
KW  - AS Ferrol
KW  - CHUF
KW  - AS Coruña
KW  - CHUAC
KW  - INIBIC
KW  - AS Ourense
KW  - CHUO
VL  - 17
ER  -